This company has been marked as potentially delisted and may not be actively trading. Cesca Therapeutics (KOOL) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisCompetitorsDividendOwnershipTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cesca Therapeutics (NASDAQ:KOOL)CurrentInstitutional OwnershipPercentage3.11%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$403.31KNumber ofInstitutional Sellers(last 12 months)0 Get KOOL Insider Trade Alerts Want to know when executives and insiders are buying or selling Cesca Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Cesca Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2025OLD Mission Capital LLC33,937$350K0.0%N/A1.405% 4/14/2025Farther Finance Advisors LLC5,405$56K0.0%N/A0.224% (Data available from 1/1/2016 forward) KOOL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KOOL shares? During the previous two years, the following institutional investors and hedge funds held shares of Cesca Therapeutics shares: OLD Mission Capital LLC ($350K), Farther Finance Advisors LLC ($56K).Learn more on Cesca Therapeutics' institutional investors. What percentage of Cesca Therapeutics' stock is owned by institutional investors? 3.11% of Cesca Therapeutics' stock is owned by institutional investors. Learn more on KOOL's institutional investor holdings. Which institutional investors have been buying Cesca Therapeutics' stock? The following institutional investors have purchased Cesca Therapeutics' stock in the last 24 months: OLD Mission Capital LLC ($33.94K), and Farther Finance Advisors LLC ($5.41K). How much institutional buying is happening at Cesca Therapeutics? Institutional investors have bought a total of 39,342 shares in the last 24 months. This purchase volume represents approximately $403.31K in transactions. Related Companies CRDL Major Shareholders BHST Major Shareholders THTX Major Shareholders GNLX Major Shareholders ATOS Major Shareholders PROC Major Shareholders ANIX Major Shareholders MDXH Major Shareholders SERA Major Shareholders LUNG Major Shareholders This page (NASDAQ:KOOL) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cesca Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cesca Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
